CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges

SIMPLE SUMMARY: Pancreatobiliary cancers are a group of malignancies affecting the pancreas and biliary tract and are among the cancers with the lowest survival rate. Current first-line treatments only offer a modest increase in overall survival, and there is an urgent need to develop new therapeuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Arsenijevic, Tatjana, Coulonval, Katia, Raspé, Eric, Demols, Anne, Roger, Pierre P., Van Laethem, Jean-Luc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913743/
https://www.ncbi.nlm.nih.gov/pubmed/36765923
http://dx.doi.org/10.3390/cancers15030968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913743/
https://www.ncbi.nlm.nih.gov/pubmed/36765923
http://dx.doi.org/10.3390/cancers15030968

Ejemplares similares